This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Special Dividend for the Financial Year Ended 31 December 2023, Payable on 22 July 2024 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable on 22 Jul 2024 CI
Y.S.P. Southeast Asia Holding Bhd. Proposes First and Final Single-Tier Ordinary Dividend in Respect of Financial Year Ended 31 December 2023 CI
Y.S.P. Southeast Asia Holding Bhd. Proposes Special Dividend in Respect of Financial Year Ended 31 December 2023 CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
YSP Southeast Asia's Profit Plunges in Q3 MT
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Appointment of Mr. Lee Sen Huei as Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Announces Retirement of Dr. Lee Fang Chuan @ Lee Fang Chen as Non Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Special Dividend for the Financial Year Ended December 31, 2022, Payable on 25, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Ordinary Dividend for the Financial Year Ended December 31, 2022, Payable on July 25, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Announces Re-Designation of Yau Teck Kong to Independent and Non Executive Chairman of Nomination Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Member of Remuneration Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Chairman of Nomination Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Member of Audit Committee CI
Y.S.P. Southeast Asia Holding Berhad Proposes Special Dividend for the Financial Year Ended 31 December 2022 CI
Y.S.P. Southeast Asia Holding Berhad Proposes First and Final Single-Tier Ordinary Dividend for the Financial Year Ended 31 December 2022 CI
Y.S.P. Southeast Asia Holding Berhad Appoints Puan Hasnah Binti Ismail as Independent and Non Executive Member of Remuneration Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Datuk Dr. Anis Re-Designated from Chairman/Independent Director to Chairman/Non Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
YSP Southeast Asia Unit Buys Property in Malaysia for MYR31 Million MT
Chart Y.S.P. Southeast Asia Holding
More charts
Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based pharmaceutical company. The Company provides a range of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products. The Company's segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Company is engaged in investment holding and provision of management services. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which provides management services in respect of product registration, trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacturing of biotechnology products and health products.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW